HIGH

Zydus Lifesciences Recalls Chlorpromazine Tablets Over Chemical Hazard

Zydus Lifesciences Ltd. recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects products with NDC 16714-050-01 due to high levels of a chemical impurity. Consumers should stop using the tablets immediately and contact healthcare providers.

Quick Facts at a Glance

Recall Date
September 3, 2025
Hazard Level
HIGH
Brands
Zydus Lifesciences, Northstar Rx LLC
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Zydus Pharmaceuticals (USA) Inc or your healthcare provider for guidance. Notification method: N/A

Product Details

The recalled product is Chlorpromazine Hydrochloride Tablets, USP, 100 mg, in 100-count bottles. The product is manufactured by Zydus Lifesciences Ltd. in Baddi, India, and distributed by Northstar Rx LLC in Memphis, TN. The affected lot numbers include Z305456, Z401156, and Z407306.

The Hazard

The recall stems from CGMP deviations due to the presence of N-Nitroso Desmethyl Chlorpromazine above acceptable limits. This impurity poses a significant risk to consumers, potentially leading to serious health issues.

Reported Incidents

No specific incidents or injuries have been reported at this time. The recall is classified as Class II, indicating a potential for serious adverse health consequences.

What to Do

Stop using the recalled tablets immediately. Contact Zydus Pharmaceuticals (USA) Inc or your healthcare provider for further guidance.

Contact Information

For more information, consumers can visit the FDA's recall page at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0637-2025.

Key Facts

  • Recalled product: Chlorpromazine Hydrochloride Tablets, 100 mg
  • Manufactured by: Zydus Lifesciences Ltd.
  • Distribution: Nationwide in the USA
  • Recall Classification: Class II
  • Chemical impurity: N-Nitroso Desmethyl Chlorpromazine

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product TypeChlorpromazine Hydrochloride Tablets
Sold At
Multiple Retailers

Product Details

Model Numbers
Lot #: Z305456
Z401156
Z407306
UPC Codes
16714-047
16714-048
16714-049
+7 more
Affected States
ALL
Report Date
September 17, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

HIGH

Acuity Specialty Products Recalls Hand Sanitizer Due to Methanol Risk

Acuity Specialty Products recalled its Wyandotte Sanifect E3 hand sanitizer on September 29, 2025. The recall affects multiple package configurations due to potential methanol contamination. Consumers should stop using the product immediately and contact the company for guidance.

Acuity Specialty Products
cGMP deviations:
Read more
HIGH

AFCO Hand Sanitizer Recalled Due to Methanol Risk

AFCO recalled hand sanitizer on September 29, 2025, due to a risk of methanol contamination. The company failed to conduct required testing on incoming alcohol components. Consumers should stop using the product immediately.

AFCO
cGMP deviations:
Read more